1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 09 FEBRUARY 2015

Cancer Drug News 09 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises
Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues
Industry Brief - Bio-Path Initiates Phase II Study Of Liposomal Grb In AML
Industry Brief - FDA Approves Imbruvica For WM
Industry Trend Analysis - Gazyva Likely To Gain NHL Indication Just Ahead Of Vast Increase In Market Size
Industry Brief - EC Approves Velcade For MCL
Industry Trend Analysis - Positive Phase II Results Could Lead To Daratumumab's Early Approval
Industry Brief - FDA Approves IND For Lion's LN-144 Phase II MM Study
Industry Brief - Theravectys' Lentiviral-Based Vaccine Gains EU Orphan Designation For ATL/L
Industry Brief - FDA Grants ODD To Ignyta's Entrectinib For Molecularly Defined Subsets Of NSCLC
Industry Brief - Dosing Begins In OncoMed's Demcizumab Phase II Trial For NSCLC
Industry Brief - IDMC Recommends Continuation Of Opaxio Phase III Maintenance Study In OC
Industry Brief - Delcath Secures Value 4 Coverage Status For Chemosat In Germany
Industry Brief - Masitinib Phase II Study Yields Encouraging Results In Metastatic GC
Industry Brief - Oncolytics Submits US Reolysin Orphan Drug Application
Industry Brief - Mekinist+Tafinlar Combination Significantly Improves OS In COMBI-d Study
Industry Brief - FDA Grants Priority Review For Yondelis In Advanced STS
Industry Brief - IDMC Recommends Continuation Of STS Phase III SIOPEL 6 Trial
Industry Brief - Zealand/Helsinn Advance Elsiglutide Into Phase IIb Development For CID
Industry Brief - Helsinn Grants Stendhal Exclusive Rights To NEPA In Multiple Countries Of Latin America
Industry Brief - G1 Raises Funds To Advance Development Of CDK4/6 Inhibitor
Industry Brief - Puma Raises Funds In Public Share Offering
Industry Trend Analysis - Synta's Workforce Slash In Line With Focus On Gaining Ganetespib Approval
Industry Trend Analysis - Celgene's Expansion Into New Therapy Areas Will Secure Future Growth
Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets

Table Of Contents

Cancer Drug News 09 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.